The Quantellect read.As of Nov 19, 2026, 6 active firms cover Kodiak Sciences Inc: 5 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The target range is very wide, $36.00 to $145.00 (about 4.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $92.33 sits 6% below the current $97.77. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.16 next quarter toward $-3.57 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Buy
Strong Buy00%
Buy583%
Neutral117%
Sell00%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$92.33
-5.6% downside
Average target across 6 active firms as of Nov 19, 2026 vs $97.77 current
Highest Target$145.00
Average Target$92.33
Lowest Target$36.00
Detailed analyst forecasts for KOD
Showing 1–6 of 6 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 5 of 6 active firms rate KOD a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
KOD EPS & revenue forecast
EPS · NEXT QUARTER
$-1.16
Range $-1.16 – $-1.16 · 1 analysts · +23% YoY
Next period, 1 analysts expect Kodiak Sciences Inc to earn $-1.16 a share (range $-1.16 – $-1.16), versus $-0.94 a year earlier. Full-year consensus is $-4.03, growing to $-3.57 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $49.3M next year.
Top analysts covering Kodiak Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KOD.
#1
Daniil Gataulin
Chardan Capital · Rank #51
Buy
$61.00-37.6% to target
Overall win rate
52%
+ Follow
#2
MC
Matthew Caufield
HC Wainwright & Co. · Rank #155
Buy
$126.00+28.9% to target
Overall win rate
49%
+ Follow
#3
Anupam Rama
JP Morgan · Rank #171
Buy
No targeton KOD
Overall win rate
48%
+ Follow
#4
Gena Wang
Barclays · Rank #410
Neutral
$17.00-82.6% to target
Overall win rate
32%
+ Follow
#5
Michael Yee
UBS
Buy
$120.00+22.7% to target
Coverage
—
+ Follow
KOD stock forecast FAQ
What is KOD's average 12-month price target?+
The 6 active firms with a live target average $92.33 for Kodiak Sciences Inc over the next 12 months, ranging from a $145.00 high to a $36.00 low, as of Nov 19, 2026.
Is KOD stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 6 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for KOD?+
The Street-high target is $145.00 (LifeSci Capital), and the Street-low is $36.00 (Goldman Sachs). The average of all 6 active-firm targets is $92.33.
How many active Wall Street firms cover KOD?+
6 active firms have a recognized rating on Kodiak Sciences Inc as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering KOD?+
Among analysts who currently cover KOD, Daniil Gataulin of Chardan Capital has the strongest overall Quantellect track record (Rank #51). Their current call is Buy with a $61.00 target.
What is Kodiak Sciences Inc's projected EPS for next quarter?+
The consensus estimate is $-1.16 per share (range $-1.16 – $-1.16) across 1 analysts. Full-year EPS is projected at $-4.03, rising to $-3.57 the following year.
How much revenue is Kodiak Sciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $49.3M next year.
Have analysts been upgrading or downgrading KOD lately?+
As of Nov 19, 2026, 5 of 6 active firms rate KOD a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KOD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.